Close
A new report from Fortanix Inc. highlights how Xeureka Inc., a subsidiary of Mitsui & Co Ltd., has utilized Fortanix's Confidential Computing technology to improve AI model accuracy in drug discovery. By leveraging AI, pharmaceutical companies can analyze vast datasets quickly and accurately, potentially leading to the discovery of new drugs at a reduced cost and time.
Xeureka aims to enhance all aspects of drug development using computer technology, with a focus on improving the efficiency and effectiveness of new drug research. Through a partnership with Fortanix and Nvidia Corp., Xeureka demonstrates the ability to integrate disparate datasets securely while maintaining data confidentiality and security.
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.
Log in
Sign Up
AI Tools - Popular
AI Tools - Categories
GPTs - Categories
AI for Jobs
